Tag: Hiv management

An undetectable viral load can be achieved in most people within six months of starting HIV treatment. However, the notion of stopping medication after achieving this milestone is a common misconception, leading many to ask: do you have to take Biktarvy forever? The answer for nearly all individuals is a definitive yes, as stopping medication carries severe health risks.

While modern antiretroviral therapy (ART) has significantly extended the lifespan of people living with HIV, studies show that older medications like tenofovir disoproxil fumarate (TDF) can contribute to kidney damage. This guide will explore the question of whether antiretroviral drugs cause kidney failure, outlining the specific risks associated with certain medications and advancements that have made treatment safer.

According to the Centers for Disease Control and Prevention (CDC), a person with HIV who achieves and maintains an undetectable viral load with ARV treatment cannot transmit the virus sexually. Knowing how to tell if my ARVs are working is crucial for optimizing health outcomes, preventing progression to AIDS, and achieving this undetectable status.

Adherence to a daily antiretroviral therapy (ART) regimen is crucial for maintaining viral suppression in people with HIV. However, when facing travel, financial issues, or forgetfulness, patients often wonder, "How long can you go without Biktarvy?" The definitive answer from healthcare professionals is that any intentional interruption of this medication carries significant health risks.

The landscape of HIV treatment has evolved significantly, with new options offering improved convenience and efficacy. A key development is the emergence of long-acting injectables like CABENUVA, which presents a significant choice for patients alongside the highly effective daily oral regimen, Biktarvy.

In 2024, an estimated 77% of people living with HIV were accessing antiretroviral therapy globally. A key question for many is, 'What is Forstavir 3 used for?' This medication is a combination drug for treating HIV-1 infection.